Showing: 70 results
Investors
About Arjo - For investors, shareholders and analysts Investors Arjo investor relations. Market-leading supplier of medical devices and solutions for patients with reduced mobility and age-related diseases. Visit us today!
Clinical Trial Research
Investigator Initiated Trials - Sponsored Trials Arjo supports clinical trial research related to our products. Read all about our requirements for sponsor support or funding for clinical trials here.
Legal Notice
This is a general disclaimer in relation to Arjo website www.arjo.com. Please note that there may be additional disclaimers and notices on the individual websites of companies within Arjo. The information published on this website is provided by Arjo AB and its affiliates (“Arjo”) for information purposes only and shall not be construed as the giving of advice or making of any recommendation, and this website should not be relied upon as the basis for any decision or action.
Soiled utility room
Allocating enough space for the use of optimal equipment allows for a safe and comfortable assisted routines that could be performed by a single caregiver.
Privacy policy
Through your use of telecommunications services to access our website, your communications data (e.g. Internet protocol address) or utilisation data (e.g. information on the beginning, end and extent of each access, and information on the telecommunications services you accessed) are technically generated and could conceivably relate to personal data. To the extent that there is a compelling necessity, the collection, processing and use of your communications or utilisation d
Terms of use
The use of these internet pages provided by Arjo and/or its subsidiaries ("Arjo "), "Arjo Web Site", is only allowed on the basis of these Terms of Use. These Terms of Use may be amended, modified or replaced by other terms and conditions, e.g. for the purchase of products and services. With log-in, or where a log-in is not required, by starting the use of the Arjo Web Site these Terms of Use are accepted in their then current version.